April 8, 2022
One applicant is allowed from each school and the UNC School of Medicine Office of Research is soliciting pre-applications from School of Medicine faculty within seven years of their terminal degree or seven years from the completion of residency.
April 6, 2022
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.
April 6, 2022
UNC’s Sasha Deutsch-Link, MD, a fellow in the Division of Gastroenterology and Hepatology, is lead author of a study indicating that alcohol-associated liver disease (ALD) mortality increased from 2017-2020 and accelerated during the COVID-19 pandemic in nearly all age groups. Andrew Moon, MD, MPH, is senior author.
April 5, 2022
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new checkpoint that cells use to control what molecules they internalize. Understanding the determinants for entry into cells could lead to the design of better therapeutics that must enter through this gatekeeping mechanism.
April 2, 2022
Kim Boggess, MD, is the co-author of a New England Journal of Medicine paper detailing important maternal and fetal health findings as part of the largest-ever clinical trial on hypertension during pregnancy.
March 31, 2022
Matthew Laughon, MD, MPH, professor of pediatrics at the UNC School of Medicine, led UNC’s site for a national clinical trial that compared the use of hydrocortisone versus placebo for preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive.
March 30, 2022
UNC-Chapel Hill scientists led by Camille Ehre, PhD, show how cells packed with SARS-CoV-2 detach from the upper airway and spread deep into lungs where severe COVID can take root. They also discovered how an asthmatic reaction to allergens battles the virus to hold severe COVID at bay.
March 25, 2022
Research led by Mark Shen, PhD, Heather Hazlett, PhD, and Joseph Piven, MD, from UNC-Chapel Hill is the first to demonstrate overgrowth of the amygdala in the first year of life, before babies show most of the behavioral symptoms that later consolidate into a diagnosis of autism. This overgrowth may be unique to autism, as babies with fragile X syndrome show a different brain growth pattern.
March 24, 2022
Matthew Vogt, MD, PhD, was awarded an R01 from NIAID to generate new monoclonal antibodies in hopes of informing pan-enterovirus vaccines.
March 24, 2022
Researchers led by Yevgeny Brudno, PhD, in the UNC-NCSU Joint Biomedical Engineering Department, have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.
March 22, 2022
Research led by Christina Cruz, MD, at the UNC School of Medicine, builds on previous research showing how teachers can successfully deliver child mental health care in a low and middle income country.
March 17, 2022
A qualitative study led by UNC School of Medicine student Lily Hale details what primary care providers and endocrine specialty clinicians reported about their patients’ self-management of diabetes during the pandemic and the effectiveness of providers’ support.